Home · Healthcare M&A · Sell a Physical Therapy Practice in NJ
PT M&A Specialist Broker · NJ · NY · CT
Nexus Bridge is the only NJ business brokerage dedicated to outpatient physical therapy M&A — connecting NJ PT practice owners with the active PE-backed buyers consolidating the tri-state in 2026. We handle the practices the national investment banks don't (single-site to 10-clinic groups, $300K–$5M EBITDA range) and bring senior-level engagement to every deal. $0 upfront. Success-only commission. Free 30-minute confidential conversation.
NJ PT practice valuations span a wide range — from 2.5× EBITDA for owner-dependent solo practices to 9×+ EBITDA for platform-eligible multi-site groups. The single biggest controllable multiple driver is owner dependency: if the owner-PT generates more than 25% of practice revenue, valuations get capped regardless of other factors. Lower owner dependency, stronger commercial payer mix, and clean Stark/AKS structure are the levers that meaningfully move the multiple.
| Practice Type | EBITDA Multiple | Key Driver |
|---|---|---|
| Single-site, owner-dependent (>50% revenue from owner-PT) | 2.5×–3.5× | Owner dependency caps valuation |
| Single-site, low owner dependency, $300K–$750K EBITDA | 3.5×–5.0× | Strong commercial payer mix lifts upper range |
| Multi-site (2–4 clinics) | 4.5×–6.5× | Regional density premium begins |
| Multi-site (5–10 clinics) | 5.5×–8.0× | Platform-eligible for PE buyers |
| Large platform (10+ sites, $5M+ EBITDA) | 9×–15× | Add-on arbitrage drives premium |
| Sports / Orthopedic PT specialty | 5.5×–8.5× | Commercial-heavy book and ortho referral lock-in |
| Pediatric PT | 5×–8× | Specialty premium (Ivy/Theraplay consolidation) |
| Hand therapy (CHT) | 5×–7.5× | Strategic interest from Confluent and Athletico |
| Pelvic floor PT | 5×–7.5× | Cash-pay premium, $150–$200/session pricing |
| Neuro / specialty rehab | 4.5×–7× | Higher per-visit revenue, smaller buyer universe |
| Cash-pay / boutique PT | 4×–6.5× | Quality-of-earnings premium; scale-capped |
| PT integrated with orthopedic practice | 5×–8× standalone | Stark/IOAS structure must be cleaned pre-sale |
| PT integrated with chiropractic | 3×–5× | Referral concentration and credentialing complexity discount |
Five-year average across all NJ PT practice transactions: ~3.6× EBITDA. Industry-wide range 2.5×–8× for single-site to mid-market practices; 9×–15× EBITDA for platforms with $5M+ EBITDA and continuing management.
The tri-state is one of the most consolidated PT markets in the United States. Ten platform companies operate ~60% of all PE-affiliated PT locations nationally; New Jersey is firmly on that trajectory. The active 2026 acquirers:
Multiple-expanding factors (in order of impact):
NJ PT practices are regulated by the NJ State Board of Physical Therapy Examiners (Division of Consumer Affairs) under N.J.S.A. 45:9-37.27 et seq. Critical point for PE M&A: only a natural person can be licensed as a PT in NJ — but the Board has confirmed that PTs may be employed by a non-licensee-owned corporation (including PE-backed entities), provided each PT maintains professional independence over clinical decisions, billing, and fee schedules. This permits the standard MSO structure used by every PE platform.
Practice structure norm: PCs or LLCs at the clinical level; PE platforms typically acquire the non-clinical management services entity (MSO) and contract for clinical services with a friendly-PC owned by NJ-licensed PT(s). Address and employment changes must be reported to the Board within 30 days. NJ has had direct access for PT since 2003 (P.L. 2003 c.18) — no physician referral required for most cases. Exception: PIP (auto injury) cases require referral from MD/DC/DPM. PT must refer out if no progress in 30 days or if condition is outside scope, and must notify the patient's PCP of plan of care within 30 days.
NY PT is regulated by the NY State Education Department / Office of the Professions (NYSED OP) under Education Law Article 136 — not the Department of Health. This is a critical distinction that PE buyers and out-of-state brokers often miss.
NY enforces strict Corporate Practice of the Professions doctrine: PTs must operate via PLLC, PC, or DPC. Physicians are explicitly prohibited from co-owning a PT PC or PLLC. A physician may employ a PT, but a physician and PT cannot be co-owners. This matters when an orthopedic group wants to acquire or jointly own a PT entity in NY. Multi-profession PLLCs are allowed if every covered profession is represented by a licensed member; PCs are single-profession only. The MSO structure is the standard PE workaround: non-clinical management entity (any owner) + clinical PC owned by NY-licensed PT.
Article 28 (NY DOH-licensed Diagnostic & Treatment Centers) generally does not apply to standalone office-based PT practices. Hospital-affiliated outpatient PT or freestanding D&TCs offering PT alongside other services may fall under Article 28 — adds significant CON/licensing complexity. NY direct access is limited (10 visits or 30 days, whichever comes first, then referral required, with PT having 3+ years of experience).
| Deal Component | 2026 Norm |
|---|---|
| Cash-at-close | 70–85% for sub-platform deals; 60–80% for larger deals with meaningful rollover |
| Rollover equity | Minimum 10%, commonly 15–20%, up to 30% (USPH partnership model can go 50%+). Rolled equity participates in the platform's "second exit" 4–7 years later. |
| Earnouts | 10–25% of total consideration, typically 2–3 year measurement, tied to EBITDA growth or visit volume targets |
| Owner-PT post-close commitment | 2–5 year employment agreements standard. Many PE platforms require selling owner to remain clinically active for at least 24 months to preserve referral relationships. |
| Owner-PT post-close compensation | Market-rate clinical salary + bonus + platform equity. Net compensation drop of 20–40% from "all the cash flow" pre-sale is normal — offset by cash-at-close and rollover equity upside. |
| Real estate | Usually handled separately. Sale-leaseback to third-party REIT or owner-retained landlord with 7–10 year triple-net lease at fair market rent is standard. PE buyers don't want real estate on the platform balance sheet. |
| Non-compete | 2–5 years; 5 years enforceable in NJ and NY under sale-of-business exception. Geographic scope usually 10–25 miles from clinics. |
| Working capital peg | Cash-free / debt-free standard. Peg set at trailing 12-month average normalized net working capital. PT-specific: A/R aging (60+ day A/R discounted in peg), unbilled visits, prepaid lease deposits. |
| Escrow / R&W holdback | 8–12% of purchase price for 12–24 months. R&W insurance increasingly common over $10M deals. |
| Quality of Earnings (QoE) | Buyer-paid and standard above ~$2M EBITDA. Sellers should commission sell-side QoE before going to market. See QoE Guide. |
The CY2026 Medicare Physician Fee Schedule final rule yields a net ~1% revenue decline for most PT practices despite a 3.26% conversion factor increase — because of permanent 2.5% efficiency adjustments to non-time-based codes including evaluation codes 97161–97164. Cumulative real-terms PT reimbursement is down ~14% since 2020. This is pushing valuation premiums toward practices with low Medicare exposure.
Direct-pay / cash-based PT has been one of the fastest-growing PT segments. Cash rates of $95–$200/session (with pelvic floor at the high end) deliver Medicare-equivalent revenue without admin burden. Buyers now pay a quality-of-earnings premium for cash-pay-heavy books — though absolute valuations remain capped by the smaller scale of most cash practices.
The February 2026 USPH–NYU Langone Health alliance is the new template — selling practices into a 10-year clinical services alliance with a major health system at 20–50% retained ownership. Expect this model to expand to Mount Sinai, Atlantic Health, RWJBarnabas Health, and Hackensack Meridian through 2027.
Post-ATI, therapist retention is the dominant deal-execution risk. Detailed retention plans, stay bonuses ($5K–$25K per key PT vesting over 2 years), and minimum-percentage closing conditions on clinical staff signing offer letters (typically 75–85% of FTE-equivalent PTs) are now standard buyer requirements.
NJ PT practices typically sell at 3×–8× EBITDA depending on size, owner dependency, and payer mix. Single-site owner-dependent practices: 2.5×–3.5×. Single-site with low owner dependency: 3.5×–5×. Multi-site (2–4 clinics): 4.5×–6.5×. Multi-site (5–10 clinics): 5.5×–8×. Large platforms ($5M+ EBITDA, 10+ sites): 9×–15×. Sports/ortho specialty: 5.5×–8.5×. Pediatric: 5×–8×. The single biggest multiple driver is owner dependency — if the owner-PT generates more than 25% of revenue, valuations get capped regardless of other factors.
Upstream Rehabilitation (Revelstoke), Professional Physical Therapy (Thomas H. Lee Partners, 60+ NJ clinics), JAG-ONE Physical Therapy (100+ NJ/NY/PA), SportsMed PT (Hildred Capital, 54 NJ/CT clinics), Ivy Rehab (Waud Capital, 36+ NJ + pediatric platform), Athletico (BDT Capital), USPH (NYU Langone alliance Feb 2026), Confluent Health/CORA (Partners Group/HIG). ATI Physical Therapy went private at $2.85/share in August 2025 and is not a likely active acquirer.
Clean mid-market NJ PT practice sales typically take 6–9 months from engagement to funded close. Multi-site portfolios take 9–12 months. NY practices add 30–60 days for multi-payer credentialing transitions. Practices with QoE issues, payer mix complexity, or referral concentration concerns extend to 10–14 months. Owner-PT typically commits to 2–3 years post-close clinical practice continuity; 3–5 year employment agreements common for sellers under 60.
70–85% cash at close. 10–30% rollover equity (USPH partnership model can go up to 50%). 10–25% earnout tied to 2–3 year EBITDA or visit volume targets. Owner-PT post-close commitment 2–5 years at market-rate clinical salary + bonus + platform equity. Real estate handled separately via sale-leaseback. Non-compete 2–5 years within 10–25 miles. Working capital peg on cash-free/debt-free basis. 8–12% escrow holdback for 12–24 months.
Yes — PT is a designated health service (DHS) under Stark. If your practice has any financial relationship with referring physicians (especially orthopedic surgeons referring Medicare patients), the structure must qualify under a Stark exception — most commonly the In-Office Ancillary Services (IOAS) exception for group practices. Stark is strict liability and PE buyers diligence this aggressively. We pre-screen Stark and AKS issues before going to market through specialty healthcare M&A counsel.
Therapist retention is the #1 concern after ATI's collapse made therapist attrition the dominant cautionary tale. PE buyers now routinely require detailed retention plans, stay bonuses ($5K–$25K per key PT vesting over 2 years), and conditioning closing on a minimum percentage of clinical staff signing offer letters (typically 75–85% of FTE-equivalent PTs). PE platforms vary widely in clinical model preservation — ProPT, JAG-ONE, and SportsMed are generally regarded as preserving clinical autonomy more than larger national chains.
No. Success-only commission. You pay nothing until your practice sells. Standard sliding scale: 10% on first $1M, 8% on $1M–$5M, sliding scale above. Sell-side QoE coordination, healthcare M&A counsel introduction, and Stark/AKS pre-screen included as part of the engagement at no additional cost.
If you own a NJ, NY, or CT physical therapy practice and are considering a sale in the next 6–36 months, schedule a free confidential 30-minute conversation. We'll review your practice profile, give you a realistic 2026 valuation range, and tell you which PE platforms fit your specific situation. $0 upfront. Success-only commission. No obligation. Response within one business day.
Related: Healthcare M&A NJ Guide · Sell an Orthopedic Practice · Sell a Medical Practice · Quality of Earnings Guide · Healthcare M&A Glossary · Medical Practice Valuation Calculator
No obligation. No upfront fee. We reply within 1 business day.